Compared to older-generation BTKis, its reduced off-target inhibition of Tec kinase in platelets and epidermal growth factor receptor (EGFR) appears to reduce the incidence of atrial fibrillation (AF), bleeding, rash, and diarrhea [3]. The gene discussed is EGFR; the disease is atrial fibrillation.